Otsuka buys commercialization rights to Lundbeck Alzhemier's disease drug

被引：0

|

作者：

Heseltine, Phoebe

机构：

来源：

FUTURE MEDICINAL CHEMISTRY | 2013年 / 5卷 / 08期

关键词：

D O I：

暂无

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

收藏

页码：863 / 863

页数：1

相关论文

共 50 条

[31] DEAL WATCH Lilly buys back into the BACE race for Alzheimer's disease
Cully, Megan
NATURE REVIEWS DRUG DISCOVERY, 2014, 13 (11) : 804 - 804
[32] Can the Law Secure Women's Rights to Land in Africa? Revisiting Tensions Between Culture and Land Commercialization
Ossome, Lyn
FEMINIST ECONOMICS, 2014, 20 (01) : 155 - 177
[33] Human Rights and Wrongs in Iran's Drug Diplomacy with Europe
Christensen, Janne Bjerre
MIDDLE EAST JOURNAL, 2017, 71 (03): : 403 - 432
[34] Can Human Rights Transcend the Commercialization of Water in South Africa? Soweto's Legal Fight for an Equitable Water Policy
Dugard, Jackie
REVIEW OF RADICAL POLITICAL ECONOMICS, 2010, 42 (02) : 175 - 194
[35] GSK acquires rights to Valeant's anti-epileptic drug
Nature Reviews Drug Discovery, 2008, 7 : 880 - 881
[36] Disease process and drug treatments in Parkinson's disease
Leenders, KL
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 (06) : 575 - 580
[37] Disease process and drug treatments in Parkinson's disease
Leenders, KL
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S9 - S10
[38] Drug treatments for Alzheimer's disease
Woodward, M
AUSTRALASIAN JOURNAL ON AGEING, 1999, 18 (02) : 59 - 65
[39] A new drug for Parkinson's disease
不详
AGE AND AGEING, 1998, 27 (04) : 422 - 422
[40] Drug adherence in Parkinson's disease
Leopold, NA
Polansky, M
Hurka, MR
MOVEMENT DISORDERS, 2004, 19 (05) : 513 - 517

← 1 2 3 4 5 →